Showing results (3551-3560 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|August 19, 2007
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokersShih-Tzu Tsai, Hong-Jun Cho, Huey-Shinn Cheng, et al.Clinical Therapeutics|August 19, 2007
Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common coldChristine Kollar, Heinz Schneider, Joel Waksman, et al.Clinical Therapeutics|August 19, 2007
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trialRichard Berger, Ronald Rizer, Alicia Barba, et al.Clinical Therapeutics|August 19, 2007
Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosisGavin Giovannoni, Olga Barbarash, Florence Casset-Semanaz, et al.Clinical Therapeutics|August 19, 2007
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimenKaren L Rascati, Manabu Akazawa, Michael Johnsrud, et al.Clinical Therapeutics|August 19, 2007
Hypertriglyceridemia and cardiovascular risk reductionTerry A Jacobson, Michael Miller, Ernst J SchaeferClinical Therapeutics|August 19, 2007
Cholesterol reduction yields clinical benefits: meta-analysis including recent trialsA Lawrence Gould, Glenn M Davies, Evo Alemao, et al.Clinical Therapeutics|August 19, 2007
Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover studyAnna Solans, Marcel Lí Carbó, Juana Peña, et al.Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.Clinical Therapeutics|August 19, 2007
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factorsBenjamin Bar-Oz, Thomas Einarson, Adrienne Einarson, et al.Pageof 680